Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4777923
Max Phase: Preclinical
Molecular Formula: C44H55N11O11S2
Molecular Weight: 978.12
Molecule Type: Unknown
Associated Items:
ID: ALA4777923
Max Phase: Preclinical
Molecular Formula: C44H55N11O11S2
Molecular Weight: 978.12
Molecule Type: Unknown
Associated Items:
Canonical SMILES: NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)c(S(=O)(=O)O)c1)C(=O)N[C@@H](CS)C(N)=O
Standard InChI: InChI=1S/C44H55N11O11S2/c45-14-6-5-11-31(41(60)53-32(42(61)55-35(22-67)39(48)58)15-23-12-13-36(56)37(16-23)68(64,65)66)51-43(62)34(18-25-21-50-30-10-4-2-8-27(25)30)54-44(63)33(52-40(59)28(46)19-38(47)57)17-24-20-49-29-9-3-1-7-26(24)29/h1-4,7-10,12-13,16,20-21,28,31-35,49-50,56,67H,5-6,11,14-15,17-19,22,45-46H2,(H2,47,57)(H2,48,58)(H,51,62)(H,52,59)(H,53,60)(H,54,63)(H,55,61)(H,64,65,66)/t28-,31-,32-,33-,34-,35-/m0/s1
Standard InChI Key: NCBMGAJLEFPYNK-DATVRVMLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 978.12 | Molecular Weight (Monoisotopic): 977.3524 | AlogP: -1.20 | #Rotatable Bonds: 25 |
Polar Surface Area: 389.90 | Molecular Species: ZWITTERION | HBA: 13 | HBD: 14 |
#RO5 Violations: 3 | HBA (Lipinski): 22 | HBD (Lipinski): 17 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: -2.15 | CX Basic pKa: 10.16 | CX LogP: -1.97 | CX LogD: -2.08 |
Aromatic Rings: 5 | Heavy Atoms: 68 | QED Weighted: 0.02 | Np Likeness Score: 0.09 |
1. Bandholtz S,Erdmann S,von Hacht JL,Exner S,Krause G,Kleinau G,Grötzinger C. (2016) Urolinin: The First Linear Peptidic Urotensin-II Receptor Agonist., 59 (22.0): [PMID:27791374] [10.1021/acs.jmedchem.6b00164] |
Source(1):